Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > EU medicines agency quits X, moves to Bluesky
    Headlines

    EU medicines agency quits X, moves to Bluesky

    Published by Global Banking & Finance Review®

    Posted on January 27, 2025

    2 min read

    Last updated: January 27, 2026

    The image features the European Medicines Agency's logo alongside the Bluesky branding, illustrating the agency's transition from X to Bluesky. This move reflects a broader trend among organizations reevaluating their presence on social media platforms amid content concerns.
    European Medicines Agency logo with Bluesky branding, symbolizing social media shift - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    The European Medicines Agency leaves X for Bluesky, citing communication needs. This move follows other organizations concerned about X's content.

    European Medicines Agency Moves from X to Bluesky Platform

    AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media platform that some have criticised for its content.

    "EMA will no longer post updates and content on X. We believe the X platform no longer suits our communication needs," the agency said in a statement.

    "After careful consideration, the Agency has decided to open an account on Bluesky."

    EMA spokespeople could not immediately be reached for further comment. A request for comment has been made to X.

    EMA's move follows other organisations that have left or pared back activity on X due to concerns about the platform's content, including the nonprofit Center for Countering Digital Hate, Germany's foreign and defence ministries, British news publisher the Guardian, and several UK universities.

    It comes at a time X's billionaire owner Elon Musk is ramping up his political campaigning in Europe, most recently by urging Germans to vote for a far-right party.

    Musk helped Donald Trump win last year's U.S. presidential election but his platform was criticised by disinformation experts for enabling the spread of falsehoods during the campaign. Musk says he wants X to champion free speech.

    Since Trump's election victory, Bluesky has added millions of users. But it remains far smaller than its rivals.

    EMA is a decentralised agency of the EU, responsible for the scientific evaluation, supervision and safety monitoring of medicines. Its headquarters are in Amsterdam, the Netherlands.

    It was regularly the centre of attention during the COVID pandemic, as it decided on the use of vaccines in the European Union.

    The European Commission and other EU institutions are still active on X. The European Central Bank earlier this month joined Bluesky, but did not quit X.

    (Reporting by Bart Meijer; Editing by Mark Potter)

    Key Takeaways

    • •EMA stops posting on X, moves to Bluesky.
    • •Decision due to X not meeting communication needs.
    • •Other organizations have also left X.
    • •Elon Musk's political activities influence platform perception.
    • •EMA played a key role during the COVID pandemic.

    Frequently Asked Questions about EU medicines agency quits X, moves to Bluesky

    1What is the main topic?

    The European Medicines Agency's decision to stop using X and switch to Bluesky for its communication needs.

    2Why did EMA leave X?

    EMA left X because it no longer meets their communication needs and due to concerns over the platform's content.

    3Who else has left X?

    Organizations like the Center for Countering Digital Hate, Germany's ministries, and the Guardian have also left X.

    More from Headlines

    Explore more articles in the Headlines category

    Image for German exports rise more than expected, industrial production falls
    German exports rise more than expected, industrial production falls
    Image for LG Energy Solution to end Canada battery JV with Stellantis
    LG Energy Solution to end Canada battery JV with Stellantis
    Image for German exports rise 4% in December
    German exports rise 4% in December
    Image for Offshore developer Orsted Q4 core profit slightly lags forecast
    Offshore developer Orsted Q4 core profit slightly lags forecast
    Image for Hungary's deficit to be around 5% of GDP this year and next, Orban says
    Hungary's deficit to be around 5% of GDP this year and next, Orban says
    Image for Germany's Merz to visit Washington in March, Die Welt reports
    Germany's Merz to visit Washington in March, Die Welt reports
    Image for In Hasina’s hometown in Bangladesh, voters face an unfamiliar ballot
    In Hasina’s hometown in Bangladesh, voters face an unfamiliar ballot
    Image for SocGen lifts profit target as retail bank offsets trading drop
    SocGen lifts profit target as retail bank offsets trading drop
    Image for Germany's PNE loses bid for Vietnam wind project, in new blow to foreign investors
    Germany's PNE loses bid for Vietnam wind project, in new blow to foreign investors
    Image for Iran, US to negotiate in Oman amid deep rifts and mounting war fears
    Iran, US to negotiate in Oman amid deep rifts and mounting war fears
    Image for Oil set for first weekly decline in seven weeks ahead of US-Iran talks
    Oil set for first weekly decline in seven weeks ahead of US-Iran talks
    Image for Britain expects Arctic security plans to be discussed by NATO next week
    Britain expects Arctic security plans to be discussed by NATO next week
    View All Headlines Posts
    Previous Headlines PostKremlin says it has yet to hear from US about setting up a possible Putin-Trump meeting
    Next Headlines PostEU Commission says it will continue gas supply talks with Ukraine